- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04966858
INpatient 이익을 최적화하기 위한 재급유에 대한 개별화된 연구 (i-STRONG)
거식증 신경성 식욕부진에 대한 재수유의 다기관 무작위 통제 시험의 갱신
The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up.
연구 개요
상태
정황
상세 설명
Atypical Anorexia Nervosa (AAN) is a new diagnosis describing patients with malnutrition and significant weight loss yet "normal" weight. These patients responded poorly to HCR, the superior refeeding treatment in the parent trial, which was designed for low-weight patients with typical AN. The proposed trial will examine the safety and efficacy of a new treatment for AAN with the potential to improve treatment outcomes for this diverse and growing patient population. The major finding motivating the proposed trial is that participants with AAN gained weight 40 percent slower and required 3.0 additional days in hospital to restore medical stability on HCR, as compared to AN. The research team has developed Individualized Caloric Refeeding (ICR), which doses calories to weight consistent with other pediatric treatments (e.g. medication).
The primary purpose of the proposed trial is to compare the efficacy and safety of ICR to the new standard of care (HCR) in hospitalized patients with AAN. The investigators hypothesize that ICR will restore medical stability faster than HCR with no increase in electrolyte abnormalities. After hospitalization, the major barrier to care in AAN is lack of consensus on clinical remission and whether these formerly overweight patients should gain weight to recover. The research team will examine metabolic, hormonal and psychological markers during long-term follow-up, toward the goal of developing a definition of clinical remission in AAN.
Design Summary: Randomized controlled trial in N=74 participants age 12-24 with AAN, consented upon hospital admission, randomly assigned to ICR or HCR, followed daily in hospital and at 3, 6, 9 and 12 mo.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
California
-
Palo Alto, California, 미국, 94304
- Stanford University Lucille Packard Children's Hospital
-
San Francisco, California, 미국, 94158
- University of California, San Francisco Benioff Children's Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Age 12-24 yrs
-
Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for AAN
-
Hospitalized with medical instability, as defined by:
- night time heart rate (HR) <45 bpm,
- systolic blood pressure (SBP) <90 mmHg,
- temperature <35.6° C,
- orthostatic Δ HR >35 bpm, or
- orthostatic Δ SBP >20 mmHg
Exclusion Criteria:
- Bulimia nervosa
- Current pregnancy
- Chronic disease (e.g. immune, renal disease)
- Acute/active suicidality or psychosis
- Hospital admissions for refeeding in the prior 6 mo.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Individualized Caloric Refeeding (ICR)
Starting 50 kcal/kg/d, increasing by 200 kcal/d to goal |
Meal-based refeeding in hospital, starting at 50 calories per kilogram of body weight, and increasing by 200 calories per day until caloric goal achieved
다른 이름들:
|
|
활성 비교기: Higher Calorie Refeeding (HCR)
Starting 2000 kcal/d, increasing by 200 kcal/d to goal |
Meal-based refeeding in hospital, starting at 2000 calories per day, and increasing by 200 calories per day until caloric goal achieved
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time to Achieve Medical Stability in Hospital
기간: Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
|
Medical stability will be adjudicated by a five-point index: (1) 24 hour heart rate of 45 beats/min or more, (2) systolic blood pressure of 90 millimeters of mercury (mmHg) or more, (3) temperature of 35.6° C or more, (4) orthostatic increase in heart rate of 35 beats/min or less, (5) orthostatic change in systolic blood pressure of 20 mmHg or less. |
Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of Low Serum Electrolytes During Refeeding in Hospital
기간: Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
|
Incidence of low electrolytes will be defined as: (1) hypophosphatemia less than 3 milligrams per deciliter (mg/dL), (2) hypomagnesaemia less than 1.8 mg/dL, and (3) hypokalemia less than 3.5 milliequivalent per liter (mEq/L) during hospitalization. |
Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Percentage Median BMI (mBMI) Over 12 Months
기간: 12 months post-study hospitalization
|
Measured BMI will be divided by the mBMI for age and sex per national growth data to give the percentage mBMI. |
12 months post-study hospitalization
|
|
Eating Disorder Examination Questionnaire (EDE-Q) Score Over 12 Months
기간: 12 months post-study hospitalization
|
The EDE-Q will be self-administered; scores range from 0 to 6, with higher scores indicating greater severity and a worse outcome. |
12 months post-study hospitalization
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Andrea K Garber, PhD, RD, University of California, San Francisco
- 수석 연구원: Neville H Golden, MD, Stanford University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 2R01HD082166-06A1 (미국 NIH 보조금/계약)
- 20-32551 (기타 식별자: UCSF IRB)
- R01HD082166 (미국 NIH 보조금/계약)
- HD082166 (기타 식별자: Federal Identifier, per NIH application)
- P0547076 (기타 식별자: NIH Application Identifier)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .